Life-saving vaccines targeting serious health conditions including cancer and heart disease could be ready within the next seven years, experts believe.
Pharmaceutical company Moderna – which produced one of the leading COVID-19 jabs – is reportedly developing “personalised” vaccines to target different types of tumours.
Moderna’s chief medical officer, Dr Paul Burton, said the treatment will be “highly effective” with the potential to save “many hundreds of thousands, if not millions of lives” as soon as 2030.
